Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
FAST: NRTI-sparing vs Standard ART after first HIV treatment failure
NCT01118871Phase 4Terminated
- Sponsor
- Imperial College London
- Start
- May 2010
- Primary completion
- May 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of etravirine in human immunodeficiency virus type 1 infection (HIV-1), sponsored by Imperial College London. Started May 2010; status: terminated.
02
Drugs
etravirine
03
Conditions
human immunodeficiency virus type 1 infection (HIV-1)
Beyond the preview
Go deeper on NCT01118871.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01118871.